PT  - JOURNAL ARTICLE
AU  - Nhu, Nguyen Thi Khanh
AU  - Phan, Minh-Duy
AU  - Hancock, Steven J.
AU  - Peters, Kate M.
AU  - Alvarez-Fraga, Laura
AU  - Forde, Brian M.
AU  - Andersen, Stacey B.
AU  - Miliya, Thyl
AU  - Harris, Patrick N.A.
AU  - Beatson, Scott A.
AU  - Schlebusch, Sanmarie
AU  - Bergh, Haakon
AU  - Turner, Paul
AU  - Brauner, Annelie
AU  - Westerlund-Wikström, Benita
AU  - Irwin, Adam D.
AU  - Schembri, Mark A.
TI  - High-risk <em>Escherichia coli</em> clones that cause neonatal meningitis and association with recrudescent infection
AID  - 10.1101/2023.10.05.23296362
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2023.10.05.23296362
4099  - http://medrxiv.org/content/early/2024/01/09/2023.10.05.23296362.short
4100  - http://medrxiv.org/content/early/2024/01/09/2023.10.05.23296362.full
AB  - Neonatal meningitis is a devastating disease associated with high mortality and neurological sequelae. Escherichia coli is the second most common cause of neonatal meningitis in full-term infants (herein NMEC) and the most common cause of meningitis in preterm neonates. Here we investigated the genomic relatedness of a collection of 58 NMEC isolates spanning 1974-2020 and isolated from seven different geographic regions. We show NMEC are comprised of diverse sequence types (STs), with ST95 (34.5%) and ST1193 (15.5%) the most common. No single virulence factor was conserved in all isolates; however, genes encoding fimbrial adhesins, iron acquisition systems, the K1 capsule, and O antigen types O18, O75 and O2 were most prevalent. Antibiotic resistance genes occurred infrequently in our collection. We also monitored the infection dynamics in three patients that suffered recrudescent invasive infection caused by the original infecting isolate despite appropriate antibiotic treatment based on antibiogram profile and resistance genotype. These patients exhibited severe gut dysbiosis. In one patient, the causative NMEC isolate was also detected in the fecal flora at the time of the second infection episode and after treatment. Thus, although antibiotics are the standard of care for NMEC treatment, our data suggests that failure to eliminate the causative NMEC that resides intestinally can lead to the existence of a refractory reservoir that may seed recrudescent infection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by National Health and Medical Research Council of Australia, Children Hospital Foundation, Australian Infectious Diseases Research Centre, Genome Innovation Hub and the Wellcome Trust.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of the Children Health Queensland Human Research gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript